Safety and Efficacy Study of CF101 to Treat Psoriasis
NCT00428974
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
76
Enrollment
INDUSTRY
Sponsor class
Conditions
Plaque Psoriasis
Interventions
DRUG:
CF101 1mg
DRUG:
CF101 2mg
DRUG:
CF101 4mg
DRUG:
Placebo
Sponsor
Can-Fite BioPharma